Gregory E. Holt

1.6k total citations
42 papers, 1.0k citations indexed

About

Gregory E. Holt is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Immunology. According to data from OpenAlex, Gregory E. Holt has authored 42 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 11 papers in Physiology and 10 papers in Immunology. Recurrent topics in Gregory E. Holt's work include Sarcoidosis and Beryllium Toxicity Research (8 papers), Immunotherapy and Immune Responses (6 papers) and Immune Response and Inflammation (4 papers). Gregory E. Holt is often cited by papers focused on Sarcoidosis and Beryllium Toxicity Research (8 papers), Immunotherapy and Immune Responses (6 papers) and Immune Response and Inflammation (4 papers). Gregory E. Holt collaborates with scholars based in United States, Canada and France. Gregory E. Holt's co-authors include Hailing Lu, Abbi L. Engel, Mehdi Mirsaeidi, Michael Campos, Lisa Künzi, Mary L. Disis, Damu Yang, Eugene D. Kwon, Naresh Kumar and Arash Sharifi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Gregory E. Holt

42 papers receiving 1.0k citations

Peers

Countries citing papers authored by Gregory E. Holt

Since Specialization

Citations

This map shows the geographic impact of Gregory E. Holt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory E. Holt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory E. Holt more than expected).

Fields of papers citing papers by Gregory E. Holt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory E. Holt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory E. Holt. The network helps show where Gregory E. Holt may publish in the future.

Co-authorship network of co-authors of Gregory E. Holt

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory E. Holt. A scholar is included among the top collaborators of Gregory E. Holt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory E. Holt. Gregory E. Holt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Metabolomics and Cytokine Signatures in COVID-19: Uncovering Immunometabolism in Pathogenesis 2025 ·Metabolites ·(unknown), Abdolrazagh Hashemi Shahraki, (unknown), Gregory E. Holt, Mehdi Mirsaeidi	1
2	Investigating Metabolic Phenotypes for Sarcoidosis Diagnosis and Exploring Immunometabolic Profiles to Unravel Disease Mechanisms 2024 ·Metabolites ·(unknown), Abdolrazagh Hashemi Shahraki, (unknown), Gregory E. Holt, Mehdi Mirsaeidi	4
3	Sarcoidosis or cancer? That is the question 2021 ·Respiratory Medicine Case Reports ·Sara Haddadi, (unknown), Gregory E. Holt, Mehdi Mirsaeidi	4
4	Effect of Face Masks on Gas Exchange in Healthy Persons and Patients with Chronic Obstructive Pulmonary Disease 2020 ·Annals of the American Thoracic Society ·(unknown), Gregory E. Holt, (unknown), Mehdi Mirsaeidi, Michael Campos	64
5	Presence of concurrent sarcoid-like granulomas indicates better survival in cancer patients: a retrospective cohort study 2020 ·ERJ Open Research ·Mukunthan Murthi, Keiichiro Yoshioka, (unknown), Sixto Arias, (unknown), (unknown), Gregory E. Holt, Koichiro Tatsumi, Takeshi Kawasaki, Mehdi Mirsaeidi	18
6	Mycobacterium Abscessus- Bronchial Epithelial Cells Cross-Talk Through Type I Interferon Signaling 2020 ·(unknown), Cui Zhang, Gregory E. Holt, (unknown), Michael Campos, Nevis Fregien, Mehdi Mirsaeidi	1
7	Anti-inflammatory effects of α-MSH through p-CREB expression in sarcoidosis like granuloma model 2020 ·Scientific Reports ·Chongxu Zhang, (unknown), (unknown), Norman H. Altman, Robert M. Jackson, Gregory E. Holt, Michael Campos, Andrew V. Schally, Mehdi Mirsaeidi	24
8	The Biological Effects of Double-Dose Alpha-1 Antitrypsin Augmentation Therapy. A Pilot Clinical Trial 2019 ·American Journal of Respiratory and Critical Care Medicine ·Michael Campos, Patrick Geraghty, Gregory E. Holt, Eliana Mendes, Paul Newby, Shuren Ma, (unknown), Gerard M. Turino, Robert A. Stockley	59
9	Cigarette smoke activates the parthanatos pathway of cell death in human bronchial epithelial cells 2019 ·Cell Death Discovery ·Lisa Künzi, Gregory E. Holt	33
10	Lung health in era of climate change and dust storms 2018 ·Environmental Research ·M.D. Schweitzer, (unknown), (unknown), Arash Sharifi, Naresh Kumar, Gregory E. Holt, Michael Campos, Mehdi Mirsaeidi	118
11	Nonstandard do-not-resuscitate orders 2018 ·Current Opinion in Anaesthesiology ·Gregory E. Holt, Kenneth W. Goodman, (unknown), (unknown)	2
12	Differences in vaping topography in relation to adherence to exclusive electronic cigarette use in veterans 2018 ·PLoS ONE ·(unknown), (unknown), (unknown), Gregory E. Holt, Mehdi Mirsaeidi, (unknown), Philip L. Whitney, Matthias Salathé, Michael Campos	12
13	Elimination of IL-10–Inducing T-Helper Epitopes from an IGFBP-2 Vaccine Ensures Potent Antitumor Activity 2014 ·Cancer Research ·Denise L. Cecil, Gregory E. Holt, Kyong Hwa Park, Ekram Gad, (unknown), Jennifer S. Childs, Doreen M. Higgins, Mary L. Disis	38
14	Dendritic Cell–Activating Vaccine Adjuvants Differ in the Ability to Elicit Antitumor Immunity Due to an Adjuvant-Specific Induction of Immunosuppressive Cells 2012 ·Clinical Cancer Research ·Yushe Dang, Wolfgang Wagner, Ekram Gad, (unknown), (unknown), Gregory E. Holt, Mary L. Disis	42
15	The pharmacokinetics of Toll-like receptor agonists and the impact on the immune system 2011 ·Expert Review of Clinical Pharmacology ·Abbi L. Engel, Gregory E. Holt, Hailing Lu	163
16	Immunotherapy as a strategy for the treatment of non-small-cell lung cancer 2010 ·Therapy ·Gregory E. Holt, Eckhard R. Podack, Luis E. Raez	41
17	Immunologic Therapies for Gastrointestinal Cancers 2005 ·Clinical Colorectal Cancer ·Benjamin Levy, John F. Deeken, Gregory E. Holt, John L. Marshall	3
18	IL-2 mRNA levels and degradation rates change with mode of stimulation and phorbol ester treatment of lymphocytes 1994 ·Cytokine ·(unknown), Charles G. Garlisi, Deborah Grove, Gregory E. Holt, Andrea M. Mastro	7
19	Culture of human fetal ovarian epithelium in a chemically-defined, serum-free medium: a model for ovarian carcinogenesis. 1990 ·PubMed ·Louis Dubeau, Mihaela Velicescu, (unknown), George J. Schreiber, Gregory E. Holt	7
20	Bedside blood gas and electrolyte monitoring in critically ill patients 1989 ·Critical Care Medicine ·Gary P. Zaloga, (unknown), Robert A. Strickland, Daniel Kennedy, (unknown), (unknown), (unknown), Gregory E. Holt, (unknown)	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact